Colorectal organ preservation in Lynch syndrome: A tailored conservative surgical approach.
Abstract
90 Background: For Lynch syndrome (LS)-associated colorectal cancers(CRC), existing guidelines prefer extended resection for cancer risk reduction. However, life-long compromises in bowel function can result. As patients increasingly value shared decision-making, we evaluated the long-term outcome of a judicious conservative surgical approach allowing colorectal organ-preservation in LS. Methods: LS patients presenting with index (first-in-life) CRC between 2006-2023 were reviewed for clinical and surveillance data. LS was defined by pathogenic germline mutation. Shared decision-making was standard; extended resection was undertaken for patient choice, left-sided colon cancer, synchronous neoplasms. Primary outcome was organ preservation, defined as retaining the majority (>50%) of the colorectum, from index CRC to last contact. Results: Over 17 years, 273 patients presented with 302 index CRCs (233 [77.1%] colon, 69 [22.2%] rectal, with 29 [9.6%] being synchronous). Extended vs. segmental resections were performed in 26 (9.5%) vs. 201(73.6%) patients. The remaining 46 (16.9%) patients had no resection (advanced endoscopic resection in 9, complete clinical response in 21, and asymptotic primary with advanced metastases in 16). The immediate organ preservation rate was 90.5% (89.9% among 257 curative-intent cases). After 1741 person-years of follow-up (mean 6.4+5.5 years), 23 metachronous CRCs underwent repeat surgical (20) or endoscopic (3) resections. The long-term organ preservation rate was 83.2% (82.1% among curative-intent cases). The rate was higher among patients with index rectal cancers. Conclusions: Over 80% of LS patient enjoyed long-term colorectal organ preservation with a judicious conversative surgical approach. It should be strongly considered in the current era of endoscopic advances, immunotherapy, and novel prevention options.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (11)
Jaganmurugan Ramamurthy
The University of Texas MD Anderson Cancer Center, Houston, TX
Oliver Peacock
The University of Texas MD Anderson Cancer Center, Houston, TX
Miguel A. Rodriguez-Bigas
The University of Texas MD Anderson Cancer Center, Houston, TX
Luigi Ricciardiello
Phillip S. Ge
The University of Texas MD Anderson Cancer Center, Houston, TX
Eduardo Vilar Sanchez
The University of Texas MD Anderson Cancer Center, Houston, TX
Selvi Thirumurthi
Craig Messick
The University of Texas MD Anderson Cancer Center, Houston, TX
Kelly R. Lovero
The University of Texas MD Anderson Cancer Center, Houston, TX
Jesse Joshua Smith
The University of Texas MD Anderson Cancer Center, Houston, TX
Y. Nancy You